Maternal coagulation disorders and postpartum hemorrhage

Clinical Obstetrics and Gynecology

Volumn 53, Issue 1, 2010, Pages 252-264

  Silver, Robert M ^a   Major, Heather ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Coagulation disorder; Hemostasis; Postpartum hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CORTICOSTEROID DERIVATIVE; DESMOPRESSIN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RHESUS D ANTIBODY; TRANEXAMIC ACID; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AFIBRINOGENEMIA; ANTIPHOSPHOLIPID SYNDROME; BERNARD SOULIER DISEASE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CRYOPRECIPITATE; DIALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COST; EVALUATION; FAMILY HISTORY; FLOW CYTOMETRY; GLANZMANN DISEASE; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOFIBRINOGENEMIA; HYPONATREMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; LABORATORY DIAGNOSIS; LIVER FATTY DEGENERATION; LYMPHOMA; MATERNAL DISEASE; MAY HEGGLIN ANOMALY; MENORRHAGIA; NEPHROTIC SYNDROME; OBSTETRIC HEMORRHAGE; OCULAR ALBINISM; PATHOPHYSIOLOGY; PLASMAPHERESIS; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PROTHROMBIN DEFICIENCY; REVIEW; SCREENING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; THYROID DISEASE; TREATMENT RESPONSE; VON WILLEBRAND DISEASE;

ALGORITHMS; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; THROMBOCYTOPENIA;

EID: 77049086608     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181cef930     Document Type: Review

References (58)

1. Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peripartum period. Thromb Res. 2009; 123(suppl 2):S63-S64.
2. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematologicalmanagement. Blood Rev. 2009;23:167-176.
3. Manten GT, Franx A, Sikkema JM, et al.. Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy. Thromb Res. 2004;114:19.
4. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med. 1988;329:142.
5. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162:731.
6. McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev. 2003; 17:7-14.
7. George JN, Woolf SH, Raskob GE, et al.. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3.
8. Lescale KB, Eddleman KA, Cines DB, et al.. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol. 1996;114:1014.
9. Cines DB, Blanchettte VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;327:995-1008.
10. Webert KE, Mittal R, Sigouin C, et al.. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003;102: 4306-4311.
11. Bussel JB, Pham LC. Intravenous treatment with gamma globulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang. 1987; 52:206.
12. Michel M, Novoa MV, Bussel JB. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Br J Haemotol. 2001;123: 1076-1078.
13. Liebman H. Other immune thrombocytopenias. Semin Hematol. 2007;44(suppl 5): S24-S34.
14. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354: 1927-1935.
15. Martin JN Jr, Bailey AP, Rehberg JF, et al.. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am J Obstet Gynecol. 2008;199:98-104.
16. Stella CL, Dacus J, Guzman E, et al.. The diagnostic dilemma of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the obstetric triage and emergency department: lessons from 4 tertiary hospitals. Am J Obstet Gynecol. 2009;200:381.e1-381.e6.
17. Bolton-Maggs PHB, Chalmers EA, Collins PW, et al.. A review of inherited platelet disorders with guidelines for their management on behalf of theUKHCDO. Br J Haematol. 2006;135:603-633.
18. Berndt MC, Gregory C, Chong BH, et al.. Additional platelet glycoprotein in Bernard- Soulier's syndrome: confirmation of genetic basis by parental analysis. Blood. 1983;62:800.
19. Jilma B. Platelet function analyzer (PFA- 100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med. 2001;138:152-163.
20. Shapiro AD. Platelet function disorders. Haemophilia. 2000;6(suppl 1):120-127.
21. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost. 1993;70: 238-240.
22. Prabu P, Parapia LA. Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol. 2006;28:198-201.
23. Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature. 1975;255:720-722.
24. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006;1:10.
25. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood. 1990;75:1383-1395.
26. Buyukasik Y, Karakus S, Goker H, et al.. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagul Fibrinolysis. 2002;13:349-353.
27. Kale A, Bayhan G, Yalinkaya A, et al.. The use of recombinant factor VIIa in a primagravida with Glanzmann's thrombasthenia during delivery. J Perinat Med. 2004;32:456.
28. Poon MC, D'Orion R, Hann I, et al.. Use of recombinant factor VIIa (Novo- Seven) in patients with Glanzmann's thrombasthenia. Semin Hematol. 2001; 38:21.
29. Bell JA, Savidge GF. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost. 2003;9:167-170.
30. Seri M, Cusano R, Gangarossa S, et al.. Mutations in MYH9 result in the May- Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet. 2000; 26:103-105.
31. Gunay-Aygun M, Huizing M, Gahl WA. Molecular defects that affect platelet dense granules. Semin Thromb Hemost. 2004;30:537-547.
32. Hayward CP. Inherited disorders of platelet al.pha granules. Platelets. 1997;8: 197-209.
33. James AH. Von Willebrand disease. Obstet Gynecol Surv. 2006;61:136.
34. Kujovich JL. VonWillebrand disease and pregnancy. J Thromb Hemost. 2004;3: 246-253.
35. Kadir RA, Lee CA, Sabin CA, et al.. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314-321.
36. James AH. More than menorrhagia: a reviewof the obstetric and gynaecological manifestations of vonWillebrand disease. Thromb Res. 2007;120:S17-S20.
37. Ramsahoye BH, Davies SV, Dasani H, et al.. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia. 1995;1:140-144.
38. Greer IA, Lowe GD, Walker JJ, et al.. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol. 1991;98:909-918.
39. Lee CA, Chi C, Pavord SR, et al.. The obstetric and gynaecological management of women with inherited bleeding disorders: review with guidelines produced by a taskforce of UK Haemophilia Centre Doctor's Organization. Haemophilia. 2006;12:301.
40. Gadisseur A, Hermans C, Berneman Z, et al.. Laboratory diagnosis and molecular classification of von Willebrand disease. Acta Haematol. 2009;121:71-84.
41. FranchiniM.Haemostasis and pregnancy. Thromb Haemost. 2006;95:401-413.
42. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost. 1981;45: 200-203.
43. Baudo F, De Cataldo F. Italian Association of Haemophilia Centres (AICE): Register of acquired factor VIII inhibitors (RIIA). Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. Br J Obstet Gynaecol. 2003; 110:311-314.
44. Franchini M, Gadini G, Paolantonio T, et al.. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55-63.
45. Girolami A, Scarano L, Saggiorato G, et al.. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis. 1998;9:557-569.
46. Horowitz MS, Pehta JC. SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang. 1998;74(suppl 1):231-235.
47. Peyvandi F, Mannucci PM, Asti M. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia. 1997;3: 242-246.
48. Condie RG. A serial study of coagulation factors XII,XI andXin plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol. 1976;83:636-639.
49. Kadir RA, Economides DL, Lee CA. Factor XI deficiency in women. Am J Hematol. 1999;60:48-54.
50. Bolton-Maggs PHB, Perry DJ, Chalmers EA, et al.. The rare coagulation disorders- review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia. 2004;10:593-628.
51. Jennings I, Kitchen S, Woods T, et al.. Problems relating to the laboratory diagnosis of FXIII deficiency: a UK NEQAS study. J Thromb Haemost. 2003; 1:2603-2608.
52. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost. 2003;29:171-174.
53. Asahina T, Kobayashi T, Takeunchi K, et al.. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv. 2007;62:255.
54. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv. 1989;44:157-161.
55. Kobayashi T, Kanayama N, Tokunaga N, et al.. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol. 2000;109:364-366.
56. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci. 2001;936:89-90.
57. Haverkate F, SamamaM. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost. 1995;73:151-161.
58. Frenkel E, Duskin C, Herman A, et al.. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature. Obstet Gynecol Surv. 2004; 59:775.